Achillion Pharma (ACHN) Reports Q3 Loss of $0.15
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Achillion Pharma (NASDAQ: ACHN) reported Q3 EPS of ($0.15), versus ($0.16) reported last year.
For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Himax Technologies (HIMX) to Neutral
- ADTRAN, Inc. (ADTN) Tops Q4 EPS by 10c
- Pinnacle Financial Partners (PNFP) Tops Q4 EPS by 2c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!